Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Patents
 More »

  • Gene by Gene Acquires GE-Backed Arpeggi
    Myriad responded last month by suing Gene to Gene and Ambry , another company announcing its own test for the BRCA genes. Myriad claimed the companies had infringed 10 patents ...
    8-7-2013
  • Rethinking Trade Secret Protection
    Given Recent Rulings on Biotech Patents, Firms Ought to Fully Protect Their Proprietary Info Judy M. Mohr, Ph.D. The traditional approach of patents to protect proprietary ...
    8-1-2013
  • CST Licenses NSCLC Dx Technology to Cepheid
    of our portfolio of patents and research in the field of improving the detection of EML4-ALK expression that enable more effective diagnosis and treatment of cancer patients." ...
    7-31-2013
  • Do VSELs Hold Water?
    in adult tissues change several dogmas in stem cell biology and challenge some patents as well," commented Mariusz Ratajczak, M.D., Ph.D., D.Sci., director of the ...
    7-31-2013
  • New Gene Patent Suit Sparks Talk of Trolls
    A month after a unanimous U.S. Supreme Court struck down seven Myriad Genetics patents ... District, claiming they infringed 10 patents associated with BRCA1 and BRCA2 that were ...
    7-23-2013
  • A Chemist's View of the Supreme Court's Gene Patent Decision
    The case before the Supreme Court is Association for Molecular Pathology et al v Myriad Genetics et al., 569 U.S. ____ (2013). Myriad was granted patents claiming, inter alia, "an ...
    7-18-2013
  • Ipsen to Acquire Syntaxin for $206M+
    of recombinant botulinum toxins-reflected by a portfolio of 75 granted patents and more than 130 patents pending-while deploying the acquired company's Targeted Secretion ...
    7-15-2013
  • Myriad Sues Ambry, Gene by Gene Amid Confusion Over Supreme Court...
    When the Supreme Court handed down its ruling on contested patents held by Myriad Genetics ... alleging that they had infringed on patents held by Myriad related to screening for ...
    7-11-2013
  • Xencor Licenses MAb Patent to Merck & Co.
    Xencor said today it awarded a nonexclusive license for one of its Fc engineering patents ... for one of the mAB's Fc engineering patents. Xencor Licenses MAb Patent to Merck & ...
    7-2-2013
  • iPSCs: Analysis of U.S. Patent Landscape
    The initial search identified approximately 230 pending and issued patents having these ... legal expertise. 177 pending applications and issued patents were selected as relevant. ...
    7-1-2013
  • Myriad to Perform BRCA Testing in CDx Deal with Tesaro
    Less than two weeks after the Supreme Court struck down its gene patents , Myriad Genetics has moved on, inking an agreement with cancer-focused biopharmaceutical company Tesaro to ...
    6-25-2013
  • A Myriad of Winners
    in overturning Myriad Genetics' seven patents related to its discovery of the precise ... companies that rely on cDNA patents for investment in innovation," declared ...
    6-17-2013
  • Macrocycles Shake Up Small Molecules
    ... protein 2 (RIP2), and salt inducible kinase 2 (SIK2). "We currently hold about 20 patents for novel kinase inhibitors that possess the unique properties of potency and ...
    6-15-2013
  • Life Tech Buys Korean Distributor LSK
    from 9,500 in 2006; a leap from 12 th to 7 th rank worldwide in peer-reviewed science and tech papers published; and a leap from 15 th to 7 th rank worldwide in technology patents. ...
    6-13-2013
  • Supreme Court Upends Patentability of Genes, but Not cDNA
    At issue is the validity of the seven patents issued to Myriad Genetics for BRCA 1 and 2 ... (PUBPAT) sued Myriad and USPTO over the patents, as well as Myriad's method for analyzing ...
    6-13-2013
  • More »

    Journal Articles

  • Ban on Medical Use Patents in Works
    Patrea L. Pabst
    Tissue Engineering, Part A
    Ban on Medical Use Patents in Works Tissue Engineering, Part A
  • Human Gene Therapy Patents in the United States: July 1, 1995...
    Breffni X. Baggot
    Human Gene Therapy and Part B: Methods
    Human Gene Therapy Patents in the United States: July 1, 1995 to June 30, 1996 Human Gene Therapy and Part B: Methods
  • Publication of U.S. Patents
    Rivka D. Monheit, Patrea L. Pabst
    Tissue Engineering, Part A
    Publication of U.S. Patents Tissue Engineering, Part A
  • Gene Therapy and Tissue Engineering Patents Abound
    Patrea L. Pabst
    Tissue Engineering, Part A
    Gene Therapy and Tissue Engineering Patents Abound Tissue Engineering, Part A

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll